Climb Bio, Inc. · NASDAQ:CLYM
Thomas Stephen Basil sold 100,000 Climb Bio, Inc. shares (Form 4)
Traded Sep 15, 2026 · Filed Sep 17, 2026
On Sep 15, 2026, Thomas Stephen Basil (Director) sold 100,000 Climb Bio, Inc. shares at US$13.67 for US$1.37M under a trading plan, leaving 467,969 shares. Filed Sep 17, 2026 (Form 4).
- Sold
- 100,000 shares
- Price
- US$13.67
- Value
- US$1.37M
- Holding after
- 467,969 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Common Stock | Sale | 100,000 | US$13.67 | 467,969 | Direct |